KOREAN
Company
Business
R & D
Investors
Company Overview
Welcome Message
Vision & Mission
History
C.I
Careers
Contact Us
Umbilical Cord Blood-derived Stem Cell
Stem Cell Therapy
Stem Cell Conditioned Media
Stem Cell Culture Media
Cell Freezing and Thawing Platform
CDMO
Health & Beauty(H&B) Business
Core Technology
Global R&D Center
Stem Cell GMP Center
Pipeline
Notice
IR
PR
Investors
Notice
IR
Disclosure Information
Stock Information
IR Resource Center
IR Letter & FAQ
PR
Press Release
PR Resource Center
Press Release
Investors
PR
Press Release
류마티스 관절염 줄기세포 치료제 1∙2a상 반복투여 개시(18.07.24)
2018/07/25 09:26:33
1. 이데일리
http://www.edaily.co.kr/news/news_detail.asp?newsId=03421046619277800&mediaCodeNo=257&OutLnkChk=Y
2. 뉴스1
http://news1.kr/articles/?3380055
3. 메트로신문
http://www.metroseoul.co.kr/news/newsview?newscd=2018072400025#cb
4. 뉴스타운
http://www.newstown.co.kr/news/articleView.html?idxno=333775
5. 메디컬투데이
http://www.mdtoday.co.kr/mdtoday/index.html?no=327534
6. 약업신문
http://www.yakup.com/news/index.html?mode=view&cat=12&nid=220476
7. 메디파나뉴스
http://medipana.com/news/news_viewer.asp?NewsNum=223095&MainKind=A&NewsKind=5&vCount=12&vKind=1
목록으로
강스템바이오텍, 주주배정 유상증자 마무리(18.07.30)
강경선 강스템바이오텍 의장 "싸고 질 좋은 줄기세포 치료제 제공하기 위해 최선 다할 것"(18.07.10)
About Us
Stock Information
Careers
Contact Us
Global R&D Center
Stem Cell GMP Center
Pipeline
TOP
pr : ir_news : view : : /pr/ir_news/view